Valneva SE announced revenue results for full year 2023. For the year, the company reported total revenues were ?153.7 million in 2023 compared to ?361.3 million in 2022. Total product sales reached ?144.6 million in 2023 compared to ?114.8 million in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.444 EUR | -0.06% | -5.95% | -27.03% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.03% | 510M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva SE Announces Revenue Results for Full Year 2023